top of page

BULLETIN


RECENT AMENDMENTS TO DRUG REIMBURSEMENT LEGISLATION
In the previous months, price discount thresholds regarding the drug reimbursements and price rates subject to drug reimbursement have...
Mar 28, 2022
TMMDA PUBLISHED FIVE GUIDELINES AND ONE DRAFT REGULATION
Turkish Medicines and Medical Devices Agency (“TMMDA”) has published five new guidelines and one draft regulation on its website in...
Mar 19, 2022
FINES FROM THE TURKISH COMPETITION AUTHORITY TO PRIVATE HOSPITALS IN BURSA AND SAMSUN
The Turkish Competition Authority has declared with its announcement dated 2 March 2022 that the investigation carried out upon the...
Mar 3, 2022
FINES FROM THE TURKISH COMPETITION BOARD TO PHARMACEUTICAL WAREHOUSES
The Turkish Competition Board (“Board”) investigated allegations regarding whether pharmaceutical manufacturers and pharmaceutical...
Mar 1, 2022
THE PRICE TAG REGULATION HAS BEEN AMENDED
The Regulation Amending the Price Tag Regulation (“Regulation”) has been published in the Official Gazette dated 18 February 2022....
Feb 22, 2022
TURKISH COMPETITION BOARD DISALLOWED BSH FROM PROHIBITING ONLINE MARKETPLACE SALES OF DISTRIBUTORS
Last week, the Turkish Competition Board (“Board”) has published the reasoning of its decision dated 16.12.2021 and numbered...
Feb 17, 2022
THE REGULATION ON THE PROVISION OF REMOTE HEALTH SERVICES HAS BEEN PUBLISHED
The Regulation on the Provision of Remote Health Services (“Regulation”) has been published in the Official Gazette dated 10 February...
Feb 14, 2022
AMENDMENTS TO THE COMMUNIQUÉ ON HEALTHCARE PRACTICES HAVE BEEN PUBLISHED IN THE OFFICIAL GAZETTE
Decisions of the Healthcare Services Pricing Commission (“HSPC Decisions”) and Communiqué Amending the Social Security Institution...
Feb 11, 2022
ÇİÇEK SEPETİ DECISION FROM THE TURKISH SUPREME COURT: INTERMEDIARY SERVICE PROVIDERS ARE NOT LIABLE
The decision of the 3rd Civil Chamber of the Turkish Supreme Court (“Chamber”) with File No. 2021/4000 and Decision No. 2021/11403...
Feb 7, 2022
THE UK COMPETITION AND MARKETS AUTHORITY HAS IMPOSED £35 MILLION FINES TO PHARMACEUTICAL FIRMS
The Competition and Markets Authority of the United Kingdom (“CMA”), which has carried out many investigations and imposed fines...
Feb 3, 2022
bottom of page
